title: Drugs & money. In the high-stakes hunt for blockbuster pharmaceuticals, companies are pouring billions each year into R & D--with no guarantee that their products will ultimately pass FDA scrutiny.
authors.forename: L
authors.initials: L
authors.lastname: Novarro
mesh_terms: D017277:Drug Approval; D004341:Drug Evaluation; D004345:Drug Industry / Q000191:economics*; D012109:Research Support as Topic / Q000191:economics / Q000639:trends*; D014481:United States; D014486:United States Food and Drug Administration